RSV vaccine development for all ages, what lies ahead of us?
On April 26, we presented the webinar: RSV vaccine development for all ages, what lies ahead of us?
In this webinar, Prof. Louis Bont, shared his views on the burden of RSV infections across generations and the latest advancements in monoclonal antibodies and vaccines against RSV.
The webinar was hosted by Leyla Kragten-Tabatabaie.
Watch the replay below:
Related webinars
Webinar: Operational Expertise in Action: Unleashing the Potential of Decentralized Clinical Trials
On October 26, we presented the webinar: Operational Expertise in Action: Unleashing the Potential of Decentralized Clinical TrialsDuring this webinar, our speaker and co-hosts, dived into Decentralized Clinical Trials and discuss the case stu...
Webinar: “RSV and Asthma”
On September 6, our partner ReSViNET presented the webinar: “RSV and Asthma”Prof Tina Hartert, MD, MPH shared her insights on RSV in relationship to asthma. Her study of almost two thousand children has identified that delay in early life ...
Webinar: Progress in RSV Vaccines and Monoclonal Antibodies
On May 10, our partner ReSViNET presented the webinar: Progress in RSV Vaccines and Monoclonal AntibodiesIn this webinar, Professor Barney Graham, MD, PhD, shared his views on the lanscape of RSV therapeutics. The webinar was hosted by Prof. D...